- Email: [email protected]
Cyto-econferences 2015-2016
Volume LII | Number 3 | MAy 2015
20152016 The 2015-2016 Cyto-econference Webinar Series has begun!
MAy 26, 2015 | 3:00 pm ET
A Walk Around The Block Donna K. Russell, MEd, CT(ASCP)HT University of Rochester Medical Center Rochester, New York Donna K. Russell, MEd, CT(ASCP)HT
Update your knowledge of body fluids and image-guided fine needle aspirations from a cytotechnology professional engaged in immediate assessment and specimen triage.
JUNE 23, 2015 | 3:00 pm ET
The Challenge of Ensuring Adequacy in the Era of Targeted Lung Cancer Therapy John M. Stewart, MD, PhD John M. Stewart, MD, PhD
University of Texas MD Anderson Cancer Center Houston, Texas
Michael J. Thrall, MD Houston Methodist Hospital Houston, Texas
In recent years, therapeutic options for lung cancer have markedly expanded. While this offers new hope for patients, it also places an increasing burden on cytologists who now need to provide more information about the type of carcinoma they are examining while preserving cells for vitally important molecular ancillary testing. Michael J. Thrall, MD
FREE Hot Topic Webinar!
MAy 13, 2015 | 3:00 pm ET
Primary HPV Screening for Cervical Cancer: Practical Implications of an Alternative Screening Option Robert A. Goulart, MD Robert A. Goulart, MD
New England Pathology Associates at Mercy Medical Center Springfield, Massachusetts
XII
20152016 The 2015-2016 Cyto-econference Webinar Series has begun!
MAy 26, 2015 | 3:00 pm ET
A Walk Around The Block Donna K. Russell, MEd, CT(ASCP)HT University of Rochester Medical Center Rochester, New York Donna K. Russell, MEd, CT(ASCP)HT
Update your knowledge of body fluids and image-guided fine needle aspirations from a cytotechnology professional engaged in immediate assessment and specimen triage.
JUNE 23, 2015 | 3:00 pm ET
The Challenge of Ensuring Adequacy in the Era of Targeted Lung Cancer Therapy John M. Stewart, MD, PhD John M. Stewart, MD, PhD
University of Texas MD Anderson Cancer Center Houston, Texas
Michael J. Thrall, MD Houston Methodist Hospital Houston, Texas
In recent years, therapeutic options for lung cancer have markedly expanded. While this offers new hope for patients, it also places an increasing burden on cytologists who now need to provide more information about the type of carcinoma they are examining while preserving cells for vitally important molecular ancillary testing. Michael J. Thrall, MD
FREE Hot Topic Webinar!
MAy 13, 2015 | 3:00 pm ET
Primary HPV Screening for Cervical Cancer: Practical Implications of an Alternative Screening Option Robert A. Goulart, MD Robert A. Goulart, MD
New England Pathology Associates at Mercy Medical Center Springfield, Massachusetts
XII